Index U

Ulcerative colitis 1059-1062, 1061t

Ulcers

aphthous 1019, 1020t-1021t

decubitus 1261-1276, 1262t, 1263f, 1265t, 1267f, 1268t, 1272t (see also Pressure sores)

Dieulafoy's 1110

foot

     in diabetes mellitus 557

Hunner's 1188

Marjolin's 1280

peptic 1042-1047 (see also Peptic ulcer disease)

pressure (see Ulcers, decubitus)

stasis 930

stress 1110

venous 1252-1254

Ultrafiltration, in acute renal failure 962

Ultrasonography

in abdominal aortic aneurysm 935

anal, in fecal incontinence 1094

in cardiovascular disorders 830

in deep vein thrombosis 925

in gallstones 1125

in ischemic stroke 408-409

in muscular disorders 515

in peripheral atherosclerosis 917

in pulmonary embolism 774, 776

therapeutic 276

transvaginal, in vaginal bleeding 1194

Ultraviolet light

in dermatitis 1250

in psoriasis 1255

Ultraviolet radiation, cutaneous effects of 1236-1238

Umbrella (Greenfield) filter 929

Undernutrition 595-603 (see also Malnutrition)

screening for 47t

Unna's boot

in lichen simplex chronicus 1251

for stasis ulcers 930

Unoprostone 1300t

Unstable angina 855, 857-858

Urea, in xerosis 1248

Ureter, tumors of 994-995

Ureterectomy 995

Ureterovaginal fistula 1202

Urethra

caruncle (prolapse) of 1200

catheterization of 979, 980

inflammation of (see Urethritis)

stenting of 979

tumors of 995-996

Urethral syndrome 995-996

Urethritis

atrophic 1209-1210

     urinary incontinence with 966

sexual activity and 1161

Uric acid 1384t

Urinalysis (see Urine, tests of)

Urinary frequency 971

Urinary incontinence 965-980, 967t, 969t, 972t, 973t, 977t

benign prostatic hyperplasia and 972, 979

drug-related 967t

established 966-971, 969t

during hospitalization 101

resources on 1415

transient 965-966, 967t

urodynamic evaluation of 975

vesicovaginal fistula and 1202

Urinary stress testing 974

Urinary tract

evaluation of 1193

infection of 39, 980-987, 981t

     colovesical fistula and 1202

     recurrent 984, 985

     urinary incontinence with 966

tumors of 987-996, 989t, 991t

Urination

evaluation of

     in benign prostatic hyperplasia 1180, 1181t

     stress testing for 974

syncope with 175

Urine

anion gap of 585

artificial reservoir for 993

concentration of 562

in dehydration 562-563

excessive output of 966, 972t

flow rate of 974

glucose in 1384

in hypokalemia 569

in hyponatremia 565t

postvoiding residual volume of 974-975, 982

protein in 1385

tests of 983-984

     in benign prostatic hyperplasia 1180

     in prostatitis 1188

     in urinary incontinence 975

Urodynamic evaluation, in urinary incontinence 975

Urokinase 700-701

in deep vein thrombosis 929

Urosepsis 985

Ursodeoxycholic acid 1072

Uterus

cancer of

     estrogen and 655, 716

     screening for 48t

prolapse of 1195, 1197, 1200

Uvulopalatopharyngoplasty 461